Fig. 2
From: Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice
The interplay between data derived from CVOTs and real world evidence for assessing the cardiovascular effects of glucose-lowering agents. RSG rosiglitazone, CVOTs cardiovascular outcome trials, RWE real world evidence, RR risk ratio